Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rune V Overgaard

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Diabetes, Obesity & Metabolism|July 27, 2018
Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approachRune V Overgaard, Søren Ø Lindberg, Desirée Thielke
Journal of Pharmacokinetics and Pharmacodynamics|May 23, 2007
Pharmacodynamic model of interleukin-21 effects on red blood cells in cynomolgus monkeysRune V Overgaard, Mats Karlsson, Steen H Ingwersen
Journal of Pharmacokinetics and Pharmacodynamics|September 22, 2005
Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithmRune V Overgaard, Niclas Jonsson, Christoffer W Tornøe, et al.
Clinical Pharmacokinetics|May 20, 2016
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic AnalysisRune V Overgaard, Kristin C Petri, Lisbeth V Jacobsen, et al.
Annals of Biomedical Engineering|July 14, 2006
Mathematical beta cell model for insulin secretion following IVGTT and OGTTRune V Overgaard, Katarina Jelic, Mats Karlsson, et al.
Diabetes, Obesity & Metabolism|May 12, 2018
Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetesKristin C C Petri, Steen H Ingwersen, Anne Flint, et al.
Cell Reports. Medicine|October 8, 2021
Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetesRune V Overgaard, Christin L Hertz, Steen H Ingwersen, et al.
Clinical Pharmacokinetics|May 10, 2021
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology TrialsRune V Overgaard, Andrea Navarria, Steen H Ingwersen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 16, 2007
A matlab framework for estimation of NLME models using stochastic differential equations: applications for estimation of insulin secretion ratesStig B Mortensen, Søren Klim, Bernd Dammann, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 17, 2009
Predictive performance for population models using stochastic differential equations applied on data from an oral glucose tolerance testJonas B Møller, Rune V Overgaard, Henrik Madsen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Diabetes, Obesity & Metabolism|July 27, 2018
Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approachRune V Overgaard, Søren Ø Lindberg, Desirée Thielke
Journal of Pharmacokinetics and Pharmacodynamics|May 23, 2007
Pharmacodynamic model of interleukin-21 effects on red blood cells in cynomolgus monkeysRune V Overgaard, Mats Karlsson, Steen H Ingwersen
Journal of Pharmacokinetics and Pharmacodynamics|September 22, 2005
Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithmRune V Overgaard, Niclas Jonsson, Christoffer W Tornøe, et al.
Clinical Pharmacokinetics|May 20, 2016
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic AnalysisRune V Overgaard, Kristin C Petri, Lisbeth V Jacobsen, et al.
Annals of Biomedical Engineering|July 14, 2006
Mathematical beta cell model for insulin secretion following IVGTT and OGTTRune V Overgaard, Katarina Jelic, Mats Karlsson, et al.
Diabetes, Obesity & Metabolism|May 12, 2018
Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetesKristin C C Petri, Steen H Ingwersen, Anne Flint, et al.
Cell Reports. Medicine|October 8, 2021
Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetesRune V Overgaard, Christin L Hertz, Steen H Ingwersen, et al.
Clinical Pharmacokinetics|May 10, 2021
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology TrialsRune V Overgaard, Andrea Navarria, Steen H Ingwersen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 16, 2007
A matlab framework for estimation of NLME models using stochastic differential equations: applications for estimation of insulin secretion ratesStig B Mortensen, Søren Klim, Bernd Dammann, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 17, 2009
Predictive performance for population models using stochastic differential equations applied on data from an oral glucose tolerance testJonas B Møller, Rune V Overgaard, Henrik Madsen, et al.
Pageof 2